According to the results of bibliometric analysis, the clinical studies about LKB1 and co-mutated genes as biomarkers in tumors, especially in lung adenocarcinoma, are the emerging hotspots and future trends. The gene discussed is STK11; the disease is lung adenocarcinoma.